Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes

Journal of Diabetes and its Complications

Volumn 27, Issue 3, 2013, Pages 293-300

  Doycheva, Iliana ^a   Patel, Niraj ^a   Peterson, Michael ^b   Loomba, Rohit ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CVD; Diabetes; Fibrosis; Insulin resistance; Metabolic syndrome; Mortality; NAFLD; NASH; Obesity

Indexed keywords

AGE; BARIATRIC SURGERY; DIABETIC HEPATOSCLEROSIS; DIABETIC PATIENT; FAMILY HISTORY; FATTY LIVER; GLUCOSE METABOLISM; GLYCOGENIC HEPATOPATHY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER HISTOLOGY; METABOLIC SYNDROME X; MORBID OBESITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FATTY LIVER; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; PROGNOSIS; RISK FACTORS;

EID: 84876893097     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.10.008     Document Type: Review

References (76)

1. L.A. Adams, S. Harmsen, J.L. St Sauver, P. Charatcharienwitthaya, F.B. Enders, and T. Therneau Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community based cohort study The American Journal of Gastroenterology 105 2010 1567 1573
2. L.E. Adinolfi, M. Gambardella, A. Andreana, M.F. Tripodi, R. Utili, and G. Ruggiero Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 2001 1358 1364
3. D.N. Amarapurkar, A.D. Amarapurkar, N.D. Patel, S. Agal, R. Baigal, P. Gupte, and S. Pramanik Annals of Hepatology 5 2006 30 33
4. P. Angulo Nonalcoholic fatty liver disease The New England Journal of Medicine 346 2002 1221 1231
5. P. Angulo, J.M. Hui, G. Marchesini, E. Bugianesi, J. George, and G.C. Farrell The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 2007 846 854
6. P. Angulo, J.C. Keach, K.P. Batts, and K.P. Lindor Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1999 1356 1362
7. P. Angulo, and K.D. Lindor Non-alcoholic fatty liver disease Journal of Gastroenterology and Hepatology 17 Suppl S 2002 186 190
8. F.N. Bashour, J.C. Teran, and K.D. Mullen Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease The American Journal of Gastroenterology 95 2000 2936 2939
9. S. Bellentani, F. Scaglioni, M. Marino, and G. Bedogni Epidemiology of non-alcoholic fatty liver disease Digestive Diseases 28 2010 155 161
10. C. Beymer, K.V. Kowdley, A. Larson, P. Edmonson, E.P. Dellinger, and D.R. Flum Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery Archives of Surgery 138 2003 1240 1244
11. C. Boza, A. Riquelme, L. Ibañez, I. Duarte, E. Norero, and P. Viviani Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass Obesity Surgery 15 2005 1148 1153
12. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions The American Journal of Gastroenterology 94 1999 2467 2474
13. E.M. Brunt, D.E. Kleiner, L.A. Wilson, P. Belt, B.A. Neuschwander-Tetri, and NASH Clinical Research Network (CRN) Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings Hepatology 53 2011 810 820
14. E. Bugianesi, G. Marchesini, E. Gentilcore, I.H. Cua, E. Vanni, M. Rizzetto, and J. George Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis Hepatology 44 2006 1648 1655
15. E. Bugianesi, F. Salamone, and F. Negro The interaction of metabolic factors with HCV infection: does it matter? Journal of Hepatology 56 Suppl. 1 2012 S56 65
16. C.D. Byrne Dorothy Hodgkin Lecture 2012* Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management Diabetic Medicine 29 2012 1098 1107
17. M. Cassader, R. Gambino, G. Musso, N. Depetris, F. Mecca, and P. Cavallo-Perin Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients Lipids 36 2001 1117 1124
18. G. Chen, and E.M. Brunt Diabetic hepatosclerosis: a 10-year autopsy series Liver International 29 2009 1044 1050
19. S. Chitturi, S. Abeygunasekera, G.C. Farrell, J. Holmes-Walker, J.M. Hui, and C. Fung NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 2002 373 379
20. J.A. Davila, R.O. Morgan, Y. Shaib, K.A. McGlynn, and H.B. El-Serag Diabetes increases the risk of hepatocellular carcinoma in the United States: a population-based case control study Gut 54 2005 533 539
21. R. de Marco, F. Locatelli, G. Zoppini, G. Verlato, E. Bonora, and M. Muggeo Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study Diabetes care 22 1999 756 761
22. J.B. Dixon, P.S. Bhathal, and P.E. O'Brien Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 2001 91 100
23. J.P. Domanski, S.J. Park, and S.A. Harrison Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter? Journal of Clinical Gastroenterology 46 2012 427 430
24. W. Dunn, R. Xu, D.L. Wingard, C. Rogers, P. Angulo, Z.M. Younosssi, and J.B. Schwimmer Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study The American Journal of Gastroenterology 103 2008 2263 2271
25. M. Ekstedt, L.E. Franzén, U.L. Mathiesen, L. Thorelius, M. Holmqvist, G. Bodemar, and S. Kechagias Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873
26. H.B. El-Serag, T. Tran, and J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 126 2004 460 468
27. J. Ertle, A. Dechene, J.P. Sowa, V. Penndorf, K. Herzer, and G. Kaiser Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis International Journal of Cancer 128 2011 2436 2443
28. A.L. Fracanzani, L. Valenti, E. Bugianesi, M. Andreoletti, A. Colli, and E. Vanni Risk of severe liver disease in nonalcoholic liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes Hepatology 48 2008 792 798
29. A. Gastaldelli, K. Cusi, M. Pettiti, J. Hardies, Y. Miyazaki, and R. Berria Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects Gastroenterology 133 2007 496 506
30. P.M. Gholam, L. Flancbaum, J.T. Machan, D.A. Charney, and D.P. Kotler Nonalcoholic fatty liver disease in severely obese subjects The American Journal of Gastroenterology 102 2007 399 408
31. P. Gupte, D. Amarapurkar, S. Agal, R. Baijal, P. Kulshrestha, and S. Pramanik Non-alcoholic steatohepatitis in type 2 diabetes mellitus Journal of Gastroenterology and Hepatology 19 2004 854 858
32. G. Guzman, E.M. Brunt, L.M. Petrovic, G. Chejfec, T.J. Layden, and S.J. Cotler Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Archives of Pathology & Laboratory Medicine 132 2008 1761 1766
33. S.A. Harrison, E.M. Brunt, Z.D. Goodman, and A.M. Di Bisceglie Diabetic hepatosclerosis: diabetic microangioapthy of the liver Archives of Pathology & Laboratory Medicine 130 2006 27 32
34. R.M. Hudacko, A.V. Manoukian, S.H. Schneider, and B. Fyfe Clinical resolution of glycogenic hepatopathy fallowing improved glycemic control Journal of Diabetes and its Complications 22 2008 320 330
35. R.M. Hudacko, J.P. Sciancalepore, and B.S. Fyfe Diabetic microangiopathy in the liver: an autopsy study of incidence and association with other diabetic complications American Journal of Clinical Pathology 132 2009 494 499
36. D.E. Kelley, T.M. McKolanis, R.A. Hegazi, L.H. Kuller, and S.C. Kalhan Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance American Journal of Physiology, Endocrinology and Metabolism 285 2003 E906 916
37. Y. Kimura, H. Hyogo, T. Ishitobi, Y. Nabeshima, K. Arihiro, and K. Chayama Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus Journal of Gastroenterology and Hepatology 26 2011 517 522
38. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
39. M. Lazo, R. Hernaez, S. Bonekamp, I.R. Kamel, F.L. Brancati, E. Guallar, and J.M. Clark Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study British Medical Journal 343 2011 d6891
40. N.C. Leite, C.A. Villela-Nogueira, V.L. Pannain, A.C. Bottino, G.F. Rezende, C.R. Cardoso, and G.F. Salles Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors Liver International 31 2011 700 706
41. M.L. Lima, S.C. Mourão, M.T. Diniz, and V.H. Leite Hepatic histopathology of patients with morbid obesity submitted to gastric bypass Obesity Surgery 15 2005 661 669
42. R. Loomba, M. Abraham, A. Unalp, L. Wilson, J. Lavine, E. Doo, N.M. Bass, and NASH Clinical Research Network Association between diabetes, family history of diabetes and risk of nonalcoholic steatohepatitis and fibrosis Hepatology 56 2012 943 951
43. G. Marchesini, E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, and R. Manini Nonalcoholic fatty liver disease, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923
44. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Boparai, Y.C. Liu, and A.J. McCullough Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
45. J. Medina, L.I. Fernández-Salazar, L. García-Buey, and R. Moreno-Otero Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis Diabetes Care 27 2004 2057 2066
46. P. Mofrad, M.J. Contos, M. Haque, C. Sargeant, R.A. Fisher, and V.A. Luketic Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values Hepatology 37 2003 1286 1292
47. N.J. Morrish, S.L. Wang, L.K. Stevens, J.H. Fuller, and H. Keen Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes Diabetologia 44 Suppl. 2 2001 S14 21
48. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219
49. M. Noureddin, I.A. Vaughn, B.A. Neuschwander-Tetri, A.J. Sanyal, A.J. McCullough, and R.B. Merriman Clinical and histological determinants of nonalcoholic steatohepatitis (NASH) and advanced fibrosis in the elderly [abstract] Hepatology 54 Suppl. 2011 1118A
50. J.P. Ong, H. Elariny, R. Collantes, A. Younoszai, V. Chandhoke, and H.D. Reines Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients Obesity Surgery 15 2005 310 315
51. K.F. Petersen, S. Dufour, A. Hariri, C. Nelson-Williams, J.N. Foo, and X.M. Zhang Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease The New England Journal of Medicine 362 2010 1082 1089
52. T. Poynard, V. Ratziu, J. McHutchinson, M. Manns, Z. Goodman, and S. Zeuzem Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C Hepatology 38 2003 75 85
53. M. Prashanth, H.K. Ganesh, M.V. Vima, M. John, T. Bandgar, and S.R. Joshi Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus Journal of the Association of Physicians of India 57 2009 205 210
54. D. Prati, E. Taioli, A. Zanella, E. Della Torre, S. Butelli, and E. Del Vacchio Updated definitions of healthy ranges for serum alanine aminotransferase levels Annals of Internal Medicine 137 2002 1 10
55. L.J. Rijzewijk, J.T. Jonker, R.W. van der Meer, M. Lubberink, H.W. de Jong, and J.A. Romijn Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes Journal of the American College of Cardiology 56 2010 225 233
56. S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, and M. Hurley The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 2002 745 750
57. A.J. Sanyal NASH: A global health problem Hepatology Research 41 2011 670 674
58. A.J. Sanyal Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C Liver International 31 Suppl1 2011 23 28
59. A.J. Sanyal, M.J. Contos, R.K. Sterling, V.A. Luketic, M.L. Shiffman, R.T. Stravitz, and A.S. Mills Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome The American Journal of Gastroenterology 98 2003 2064 2071
60. A.J. Sanyal, S.K. Yoon, and R. Lencioni The etiology of hepatocellular carcinoma and consequences for treatment Oncologist 15 Suppl 4 2010 14 22
61. J.F. Silverman, K.F. O'Brien, S. Long, N. Leggett, P.G. Khazanie, and W.J. Pories Liver pathology in morbidly obese patients with and without diabetes The American Journal of Gastroenterology 85 1990 1349 1355
62. B.W. Smith, and L.A. Adams Non-alcoholic fatty liver disease Critical Reviews in Clinical Laboratory Sciences 48 2011 97 113
63. L. Spaulding, T. Trainer, and D. Janiec Prevalence of non-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass Obesity Surgery 13 2003 347 349
64. Y. Takuma, and K. Nouso Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review World Journal of Gastroenterology 16 2010 1436 1441
65. G. Targher, L. Bertolini, R. Padovani, S. Rodella, R. Tessari, and L. Zenari Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients Diabetes Care 30 2007 1212 1218
66. G. Targher, L. Bertolini, F. Poli, S. Rodella, L. Scala, and R. Tessari Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients Diabetes 54 2005 3541 3546
67. G. Targher, L. Bertolini, S. Rodella, R. Tessari, L. Zenari, G. Lippi, and G. Arcaro Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients Diabetes Care 30 2007 2119 2121
68. M. Torbenson, Y.Y. Chen, E. Brunt, O.W. Cummings, M. Gottfried, and S. Jakate Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus The American Journal of Surgical Pathology 30 2006 508 513
69. M. Trompetta, G. Spiazzi, G. Zoppini, and M. Muggeo Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study Alimentary Pharmacology and Therapeutics 22 Suppl 2 2005 24 27
70. M. van den Brand, L.D. Elving, J.P. Drenth, and J.H. van Krieken Glycogenic hepatopathy: a rare cause of elevated serum transaminases in diabetes mellitus The Netherlands Journal of Medicine 67 2009 394 396
71. A.L. Williams, and J.H. Hoofnagle Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis.Relationship to cirrhosis Gastroenterology 95 1988 734 739
72. C.D. Williams, J. Stengel, M.I. Asike, D.M. Torres, J. Shaw, and M. Contreras Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 2011 124 131
73. R.M. Williamson, J.F. Price, S. Glancy, E. Perry, L.D. Nee, and P.C. Hayes Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study Diabetes Care 34 2011 1139 1144
74. V.W. Wong, H.L. Chan, A.Y. Hui, K.F. Chan, C.T. Liew, F.K. Chan, and J.J. Sung Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese Alimentary Pharmacology and Therapeutics 20 2004 45 49
75. Z.M. Younossi, T. Gramlich, C.A. Matteoni, N. Boparai, and A.J. McCullough Nonalcoholic fatty liver disease in patients with type 2 diabetes Clinical Gastroenterology and Hepatology 2 2004 262 265
76. Z.M. Younossi, M. Stepanova, M. Afendy, Y. Fang, Y. Younossi, H. Mir, and M. Srishord Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008 Clinical Gastroenterology and Hepatology 9 2011 524 530